Primary |
Hypertension |
61.0% |
Product Used For Unknown Indication |
11.0% |
Drug Use For Unknown Indication |
5.5% |
Blood Pressure Increased |
2.2% |
Type 2 Diabetes Mellitus |
2.2% |
Coronary Artery Disease |
2.1% |
Diabetes Mellitus |
2.1% |
Depression |
1.9% |
Essential Hypertension |
1.8% |
Blood Pressure |
1.3% |
Blood Cholesterol Increased |
1.2% |
Pain |
1.2% |
Oedema Peripheral |
1.1% |
Hyperlipidaemia |
1.0% |
Cardiovascular Disorder |
0.9% |
Osteoarthritis |
0.9% |
Bacterial Infection |
0.7% |
Oedema |
0.7% |
Anxiety |
0.6% |
Diuretic Therapy |
0.6% |
|
Syncope |
15.6% |
Hyponatraemia |
15.2% |
Vomiting |
9.9% |
Renal Failure Acute |
8.9% |
Hypokalaemia |
7.4% |
Hypotension |
5.5% |
Rash |
5.1% |
Pancreatitis |
4.4% |
Rhabdomyolysis |
2.9% |
Completed Suicide |
2.5% |
Dehydration |
2.5% |
Inappropriate Antidiuretic Hormone Secretion |
2.5% |
Dizziness |
2.3% |
Pancreatitis Acute |
2.3% |
Torsade De Pointes |
2.3% |
Vertigo |
2.3% |
Vision Blurred |
2.3% |
Angioedema |
2.1% |
Death |
2.1% |
Urinary Tract Infection |
2.1% |
|
Secondary |
Hypertension |
34.2% |
Product Used For Unknown Indication |
30.2% |
Drug Use For Unknown Indication |
14.3% |
Type 2 Diabetes Mellitus |
2.8% |
Diabetes Mellitus |
2.3% |
Depression |
2.1% |
Pain |
1.4% |
Essential Hypertension |
1.3% |
Coronary Artery Disease |
1.2% |
Hyperlipidaemia |
1.2% |
Atrial Fibrillation |
1.1% |
Rheumatoid Arthritis |
1.1% |
Breast Cancer |
1.0% |
Prophylaxis |
1.0% |
Blood Pressure |
0.9% |
Osteoporosis |
0.9% |
Hypothyroidism |
0.8% |
Cardiac Failure |
0.7% |
Gastrooesophageal Reflux Disease |
0.7% |
Supplementation Therapy |
0.7% |
|
Completed Suicide |
14.9% |
Syncope |
11.9% |
Renal Failure Acute |
10.0% |
Vomiting |
9.3% |
Hyponatraemia |
6.7% |
Hypotension |
4.1% |
Weight Decreased |
4.0% |
Drug Hypersensitivity |
3.9% |
Weight Increased |
3.8% |
Toxicity To Various Agents |
3.6% |
Death |
3.4% |
Drug Ineffective |
3.4% |
Hypokalaemia |
3.0% |
Renal Failure |
3.0% |
Sudden Death |
2.8% |
Hypertension |
2.6% |
Myocardial Infarction |
2.6% |
Dizziness |
2.4% |
Nausea |
2.3% |
Respiratory Arrest |
2.3% |
|
Concomitant |
Product Used For Unknown Indication |
24.9% |
Hypertension |
20.8% |
Drug Use For Unknown Indication |
14.7% |
Rheumatoid Arthritis |
4.7% |
Pain |
3.8% |
Diabetes Mellitus |
3.6% |
Depression |
3.3% |
Blood Cholesterol Increased |
3.1% |
Blood Pressure |
2.4% |
Type 2 Diabetes Mellitus |
2.3% |
Gastrooesophageal Reflux Disease |
2.1% |
Osteoporosis |
2.1% |
Asthma |
1.9% |
Prophylaxis |
1.7% |
Atrial Fibrillation |
1.7% |
Anxiety |
1.6% |
Chronic Obstructive Pulmonary Disease |
1.5% |
Arthritis |
1.2% |
Multiple Sclerosis |
1.2% |
Multiple Myeloma |
1.2% |
|
Vomiting |
12.0% |
Weight Decreased |
11.2% |
Weight Increased |
8.8% |
Nausea |
6.4% |
Drug Ineffective |
6.0% |
Myocardial Infarction |
5.0% |
Pain |
4.9% |
Pruritus |
4.0% |
Pain In Extremity |
3.9% |
Rash |
3.8% |
Flushing |
3.8% |
Vision Blurred |
3.8% |
Somnolence |
3.5% |
Urinary Tract Infection |
3.5% |
Dyspnoea |
3.4% |
Pneumonia |
3.3% |
Type 2 Diabetes Mellitus |
3.3% |
Tremor |
3.2% |
Death |
3.2% |
Urticaria |
3.1% |
|
Interacting |
Product Used For Unknown Indication |
41.5% |
Hypertension |
25.7% |
Dementia |
3.6% |
Coronary Artery Disease |
3.1% |
Depression |
3.0% |
Pain |
2.6% |
Drug Use For Unknown Indication |
2.5% |
Convulsion |
2.1% |
Hyperlipidaemia |
2.1% |
Type 2 Diabetes Mellitus |
1.8% |
Cardiac Failure |
1.6% |
Polyneuropathy Alcoholic |
1.5% |
Blood Pressure Abnormal |
1.3% |
Essential Hypertension |
1.3% |
Prophylaxis |
1.2% |
Atrial Fibrillation |
1.0% |
Bipolar I Disorder |
1.0% |
Chronic Obstructive Pulmonary Disease |
1.0% |
Crohn's Disease |
1.0% |
Rheumatoid Arthritis |
1.0% |
|
Drug Interaction |
24.7% |
Tremor |
10.1% |
Renal Failure Acute |
7.9% |
Syncope |
7.9% |
Dizziness |
5.6% |
Feeling Abnormal |
4.5% |
Hyponatraemia |
4.5% |
Dehydration |
3.4% |
Hypotension |
3.4% |
Palpitations |
3.4% |
Thirst |
3.4% |
Toothache |
3.4% |
Hypoaesthesia |
2.2% |
Hypokalaemia |
2.2% |
Inappropriate Antidiuretic Hormone Secretion |
2.2% |
Mania |
2.2% |
Neuralgia |
2.2% |
Potentiating Drug Interaction |
2.2% |
Rash Papular |
2.2% |
Renal Failure |
2.2% |
|